U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Royalty Pharma

Market Cap: US$20.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Regeneron Pharmaceuticals

Market Cap: US$58.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

CorMedix

Market Cap: US$907.8m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Jazz Pharmaceuticals

Market Cap: US$8.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Decibel Cannabis

Market Cap: US$77.9m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Evolus

Market Cap: US$397.2m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Journey Medical

Market Cap: US$187.3m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Perrigo

Market Cap: US$3.1b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Amneal Pharmaceuticals

Market Cap: US$3.1b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Sanofi

Market Cap: US$103.6b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Telix Pharmaceuticals

Market Cap: US$5.1b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

CSL

Market Cap: US$96.1b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Organon

Market Cap: US$2.8b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Cresco Labs

Market Cap: US$810.1m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Evotec

Market Cap: US$1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

ARS Pharmaceuticals

Market Cap: US$993.2m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Viatris

Market Cap: US$11.5b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Curaleaf Holdings

Market Cap: US$2.9b

Produces and distributes cannabis products in the United States and internationally.

AVITA Medical

Market Cap: US$155.8m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Trulieve Cannabis

Market Cap: US$2.1b

Operates as a cannabis retailer.

UroGen Pharma

Market Cap: US$923.0m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Abeona Therapeutics

Market Cap: US$270.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Axsome Therapeutics

Market Cap: US$6.1b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Avantor

Market Cap: US$8.5b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Bayer

Market Cap: US$29.1b

Operates as a life science company worldwide.

Sarepta Therapeutics

Market Cap: US$1.9b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Biogen

Market Cap: US$20.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Halozyme Therapeutics

Market Cap: US$8.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Shionogi

Market Cap: US$2.2t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

Veru

Market Cap: US$55.7m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Otsuka Holdings

Market Cap: US$4.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.